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Abstract
Diagnostic communication between physicians and patients is thought to be one 
of the most important factors regardless of cultural differences. However, culture 
infl uences people’s thinking, feeling, and behavior in both obvious and subtle ways. 
Furthermore, cultural and social factors play a signifi cant role in eating and work-
ing patterns, the quality of relationships, attitudes toward life and death, and re-
sponse to illness.
Although Japan and the United States are both the developed countries and they 
have the highly developed medical techniques, their attitudes and thoughts toward 
diagnostic disclosure and the relationship between physicians and patients are dif-
ferent, and one of the possible reasons for that is cultural differences.
The purpose of this paper is to investigate the difference in disclosing informa-
tion toward patients, taking into account the physician-patient relationship in both 
Japan and the United States, from communicative perspective.
Comparison of Diagnostic Disclosure in Japan and the United States
Generally speaking, Japanese physicians historically have not disclosed diagno-
ses to patients especially when the diagnosed result is negative, whereas American 
physicians have disclosed to patients because of a respect for patient autonomy. 
Regarding informed consent, it has become an essential component in ensuring that 
patients become knowledgeable participants in choosing health care options in the 
United States. In Japan, however, the concept of informed consent has not yet been 
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generally accepted by the medical profession; it implies that the right of the patient 
to take part in the decision-making process to a large extent remains ignored (Hat-
tori, Salzberg, Kiang, Fujimiya, Tejima, & Furuno, 1991). In the United States, No-
vak et al. (1979) reported that 95% of cancer patients were told their diagnosis at 
the time the disease was found. Contrarily, in Japan, giving diagnosis of cancer to 
patients still remains controversial, though in 1989 the Japanese Ministry of Health 
and Welfare and the Japan Medical Association suggested that doctors should tell 
patients with limited life expectancies as well as terminally ill patients of their di-
agnosis.
The issue of diagnostic disclosure to patients relates to several complicated fac-
tors, such as the patient’s character, the patient’s relatives’ wishes, the degree of the 
illness, religious and cultural background, physicians’ attitudes, and hospital policy. 
The aim of this paper is to examine cultural and social norms and present notions 
in medical settings by investigating the difference in disclosure of information in 
Japan and the United States.
The United States
A generation ago, American physicians seldom told patients the diagnosis of 
cancer; today, there is virtual unanimity in the United States on the ethical and 
legal obligation to disclose the diagnosis (Good, Good, Schaffer, & Lind, 1990). 
In the United States, the practice of nondisclosure was seen well into the 1960’s. 
According to Oken (1961), eighty-eight percent of physicians surveyed in 1961 re-
ported their usual practice was not to tell the patient of the cancer diagnosis. How-
ever, during the social upheaval in that country of the 1960’s and 1970’s, demands 
by patients for more information and participation in their care became recognized 
in law and medical ethics (Elwyn, Fetters, Grenfl o, & Tsuda, 1998). Trill and Hol-
land (1993) discussed the idea that information regarding disease and treatment 
option is conveyed to the patients in keeping with the patients’ rights movement, 
and also because of the need for the patients to reach a positive and informed deci-
sion regarding treatment choice in the United States. As a result, in a 1979 survey, 
98% of respondents reported a usual policy of telling the patients (Novak, Plumer, 
Smith, Ochitill, Morrow, & Bennett, 1979).
From Americans’ viewpoint, providing information has possibility to establish 
a relationship of openness and trust and increase the patients’ autonomy, a value 
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in itself. This should enhance the patients’ motivation to participate in an active, 
therapeutic partnership. In other words, telling the truth and giving information to 
patients are defi ned as a physicians’ duty, and knowing the truth and seeking infor-
mation are defi ned as a patients’ right in the United States.
In terms of disclosure on hope, Good et al. (1990) discussed that “the American 
disclosure on hope incorporates popular and professional dimensions of our culture 
of biomedicine”(p.61). They also state that the emphasis of “will” articulates fun-
damental American notions about personhood, individual autonomy, and the power 
of thought (good or bad) to shape life course and bodily functioning. Thus, these 
fundamental American notions about the “will” and the relationship of the will to 
somatic and psychological manifestations of disease and cure influence how dis-
closure and hope are expressed in medical disclosure and practice in the American 
context. In addition to that, it is also important that disclosure is viewed as essen-
tial to establishing partnerships with patients and the construction of a partnership 
is understood as a necessary component of treatments.
Japan
The Japanese approach to ethical issues in health care has been characterized by 
the Japanese cultural values of consensus and deference to authority (Hattori et al., 
1991). Physicians bear the responsibility to decide the course of patient care, and 
patients also expect physicians to give them exact advice and diagnoses. In Japan, 
it is rare that patients challenge physicians’ diagnoses. Kim, Holter, and Lorensen 
(1993) found that the Japanese patients were the least challenging of professional 
authority compared to the Finnish, the Norwegians, and the U.S.A patients. Con-
cerning giving information to patients, according to Elwyn et al.’s study (1998), 
the number of physicians usually telling the patients of a cancer diagnosis in the 
United States was over three times that in Japan in 1991.
Withholding of information is popularly associated with a medical authoritarian-
ism rooted in feudal values, in which the people are expected to simply comply 
with orders. “The patients leave all decisions to the doctors, follow their advice, 
and do not question what they are told” (McDonald-Scott, Machizawa, & Satoh, 
1992). Information fl ows from the physician above to the patient below. Persistent 
questioning by the patients is viewed as an arrogant challenge to authority. The 
respect for, and perceived authority of, physicians in Japan was very strong before 
78
the Second World War, and patients fully entrusted physicians with total and fi nal 
decision-making authority with respect to their own medical treatment. This ten-
dency was consonant with the prevailing cultural and historical context in Japan. 
In these days, however, because universal disclosure promotes the patients’ right 
to know the diagnosis, the traditional relationship between physician and patient, 
which is closely akin to the teacher-student relationship in Japan and involves great 
deference to the physician’s advice and decisions, has been vanishing. On the other 
hand, theoretical issues and practical ones are sometimes contradicted. Contrary 
to the movement of promoting disclosure of information to patients, in terms of 
emotional aspects, Japanese are more likely to agree that informing would hurt the 
patients and thereby negatively infl uence treatment. For example, the late Japanese 
Emperor Hirohito passed away in early 1989 without ever realizing that he had 
intestinal cancer (Morioka, 1991). This fact represents the Japanese traditional way 
of dealing with the terminal patients. Thus, regarding disclosing information to 
patients, Japan has several complicated issues involved cultural factors with strug-
gling with the question of whether to tell patients their diagnosis or not.
The patient as Individual; The patient as Family Member
According to McDonald-Scott et al. (1992), Japanese physicians are more likely 
to inform a family member of the diagnosis but not the patient first whereas the 
Americans also inform the family, but only with the permission of the patients. 
From American points of view, the family is viewed as a distinct adjunct. To in-
form only the family is untenable. “In the United States, a long tradition of empha-
sizing personal autonomy extends naturally to using advance directives in medical 
decision making”(Sehgal, Weisheil, Miura, Butzlaff, Kielstein, and Taguchi, 1996, 
p.1655). Atkinson (1989) discusses that it puts the family in the uncomfortable sit-
uation of having to inform the patients themselves or to guard against the patients 
fi nding out, and it violates the patients’ right to autonomy.
In contrast, Japanese tend to see themselves as members of a larger family, 
rather than viewing the patients solely as an individual. In other word, the family 
is defi ned as the primary social unit (Harrison, Al-Saadi, Al-Kaabi, Al-Kaabi, Al-
Dedwawi, Al-Kaabi, & Al-Neaimi, 1997). As the patients’ family, they have the 
right to know their members’ illness. Seo et al. (2000) stated that one of the rea-
sons why cancer patients were not told the diagnosis was that their family objected. 
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The study, examining 1918 bereaved family members who had cared for cancer pa-
tients, found only 18% of patients were informed of the diagnosis of cancer, while 
all family members were told about the patient’s condition precisely (Uchitomi & 
Yamawaki, 1997). They also mentioned that it is still a Japanese custom that phy-
sicians usually explain about the patient’s condition to family members first, and 
once the family members agree, the patients are informed. “Medical physicians in 
Japan usually inform the family or close relatives of the existence of the cancer but 
tell the patient that he has a benign disease”(Hattori et al, 1991, p.1014). In terms 
of substitute consent, it is only acceptable in the United States when the patient is 
psychiatrically incompetent or in emergency conditions, whereas in Japan, even in 
cases where the patients are competent to give their individual consent, substitute 
consent by the family or close relatives is a common practice in order to avoid dis-
turbing the patient emotionally.
Therefore, the involvement of family members in the decision-making process in 
Japan is much higher than in the United States.
Regarding the different perspectives toward a “patient” between Japan and the 
United States, it is worth stating that the notion of “personhood” or “self” in Japa-
nese society is quite different from that of the “individual” in American society. 
Accordingly, the individual in the United States is conceived to be autonomous, 
while in Japanese society a person is structurally defi ned in relation to family and 
close friends. Furthermore, from human-relational perspective, if a family member 
or friend is threatened with death, the Japanese feel that they should let the patients 
die in peace (a concept called “Yasuragi” ), without making them go through the 
agony of knowing their condition. This leads to the practice whereby most of the 
decisions relating to a patient’s medical care are left to the family members and 
results in the prevalence of substitute consent. These possible reasons why family 
members and close friends sometimes make major decisions for an individual in 
Japan.
Conclusion
This paper investigates the differences in disclosing information while consider-
ing the physician-patient relationship between Japan and the United States from 
communicative perspective. Japanese society places more emphasis on the social 
relatedness of human beings than on the individualistic notion of the autonomous 
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self, while American society places emphasis on autonomy and individual responsi-
bility. Under these circumstances, each country has its own problems.
In the United States, respect for patient autonomy works well for the vast major-
ity of patients who want to be told. However, for the minority of patients who do 
not want wish to be told themselves, blindly following this practice may yield a 
harmful outcome (Elwyn et al. 1998). In Japan, while physicians appear to be mov-
ing toward relationships of greater openness with their patients, with the movement 
of promoting to disclose information to the patients as human’s right on a world 
scale, the outcry for more disclosure is not a demand for complete disclosure to 
all patients, since there are still many Japanese who do not wish to be told if diag-
nosed with a terminal illness.
Since the issue of disclosing information to patients has involved complicated 
cultural and historical backgrounds, we can not make that kind of sweeping gen-
eralization. However, the fundamental goal of both countries in terms of keeping 
good relationships between physicians and patients is to achieve a balance between 
autonomy and dependency such that patients’ and the family’s needs are met in the 
most satisfactory way.
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